aspirin has been researched along with ursodeoxycholic acid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bonorris, GG; Marks, JW; Schoenfield, LJ | 1 |
| Bonorris, GG; Broomfield, PH; Chopra, R; Marks, JW; Schoenfield, LJ; Sheinbaum, RC; Silverman, A | 1 |
| Sahlin, S | 1 |
| Shiffman, ML; Sterling, RK | 1 |
| Arslan, I; Harman, M; Meral, C; Mercan, R; Oztürk, M; Tuncer, I; Türkdoğan, MK | 1 |
| Kroesen, A; Pox, C; Schmiegel, W | 1 |
| Gill, S; Sinicrope, FA | 1 |
| Becker, JC; Domschke, W; Pohle, T | 1 |
| Farinati, F; Herszényi, L; Miheller, P; Tulassay, Z | 1 |
| Almada, LL; Buttar, NS; Comba, A; Demars, CJ; Fernández-Zapico, ME; Gainullin, VG; Lomberk, G; Rizvi, S; Rizvi, Z; Wang, K | 1 |
5 review(s) available for aspirin and ursodeoxycholic acid
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Topics: Adenoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Calcium; Clinical Trials as Topic; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Eflornithine; Folic Acid; Humans; Intestinal Mucosa; Selenium; Ursodeoxycholic Acid | 2005 |
[Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Gastritis; Gastrointestinal Neoplasms; Health Behavior; Helicobacter Infections; Helicobacter pylori; Humans; Life Style; Randomized Controlled Trials as Topic; Risk Factors; Ursodeoxycholic Acid; Virulence | 2006 |
Chemoprevention of colorectal cancer: feasibility in everyday practice?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Chemoprevention; Clinical Trials as Topic; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Dietary Supplements; Family Practice; Feasibility Studies; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mesalamine; Ursodeoxycholic Acid | 2008 |
2 trial(s) available for aspirin and ursodeoxycholic acid
| Article | Year |
|---|---|
Roles of deoxycholate and arachidonate in pathogenesis of cholesterol gallstones in obese patients during rapid loss of weight.
Topics: Arachidonic Acid; Arachidonic Acids; Aspirin; Cholelithiasis; Cholesterol; Deoxycholic Acid; Dinoprostone; Double-Blind Method; Glycoproteins; Humans; Obesity; Ursodeoxycholic Acid; Weight Loss | 1991 |
Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
Topics: Adult; Aspirin; Bile; Cholelithiasis; Cholesterol; Crystallization; Deoxycholic Acid; Double-Blind Method; Female; Glycoproteins; Humans; Male; Ursodeoxycholic Acid; Weight Loss | 1988 |
8 other study(ies) available for aspirin and ursodeoxycholic acid
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Topics: Aspirin; Bile; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Female; Humans; Lipids; Male; Middle Aged; Prospective Studies; Proteins; Ursodeoxycholic Acid | 1996 |
Nonsteroidal antiinflammatory drugs and gallstone disease: will an aspirin a day keep the gallstones away?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cholagogues and Choleretics; Cholelithiasis; Cholesterol; Humans; Mucins; Ursodeoxycholic Acid | 1998 |
The effects of ursodeoxycholic acid alone and ursodeoxycholic acid plus low-dose acetylsalicylic acid on radiolucent gallstones.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cholagogues and Choleretics; Cholecystolithiasis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ursodeoxycholic Acid | 2003 |
[Ulcerative colitis. Cancer prevention].
Topics: Adenoma; Adenomatous Polyposis Coli; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Case-Control Studies; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colectomy; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Cross-Sectional Studies; Female; Folic Acid; Follow-Up Studies; Humans; Male; Meta-Analysis as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Ursodeoxycholic Acid | 2004 |
Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Aspirin; Barrett Esophagus; Cell Growth Processes; Cyclin-Dependent Kinase 2; Disease Models, Animal; Down-Regulation; Esophageal Neoplasms; Humans; Oncogene Proteins; Promoter Regions, Genetic; Protein Binding; Rats; Trans-Activators; Transfection; Ursodeoxycholic Acid; Zinc Finger Protein GLI1 | 2010 |